| IPSS reduction | Volume reduction | ||
---|---|---|---|---|
mean | SD | mean | SD | |
BPH type according to Wasserman | ||||
 type 1 (n = 18) | 56% | 33% | 25% | 11% |
 type 2 (n = 5) | 45% | 34% | 26% | 10% |
 type 3 (n = 15) | 54% | 24% | 22% | 14% |
 type 4 (n = 1) | 45% | na | 28% | na |
 type 5 (n = 17) | 38% | 56% | 25% | 13% |
 p-value* | 0.60 | 0.88 | ||
simplified BPH classification | ||||
 preurethral (n = 27) | 52% | 33% | 25% | 11% |
 retrourethral (n = 9) | 50% | 29% | 29% | 10% |
 biurethral (n = 30) | 45% | 49% | 22% | 14% |
 p-value* | 0.59 | 0.88 | ||
PAE unilateral vs. bilateral | ||||
 Unilateral (n = 7) | 21% | 85% | 14% | 14% |
 Bilateral (n = 59) | 52% | 29% | 26% | 12% |
 p-value** |  < 0.01 |  < 0.01 | ||
presence of AdBPH | ||||
 non-AdBPH (n = 13) | 36% | 38% | 21% | 13% |
 AdBPH (n = 53) | 51% | 39% | 25% | 9% |
 p-value** |  < 0.01 |  < 0.01 | ||
volume groups | ||||
 < 100 ml (n = 43) | 43% | 43% | 23% | 12% |
 > 100 ml (n = 23) | 59% | 27% | 26% | 13% |
 p-value** |  < 0.01 |  < 0.04 |